AFP and metabolic dysfunction-associated steatotic liver disease: Besides US and AFP, a substantial number of clinical prediction scores are available to estimate the stage of fibrosis, grade of steatosis, or the risk of HCC in NAFLD patients, with different levels of clinical utility and validation [148,149].